MAPT and Alzheimer disease: For the 18F‐AV‐1451 regional analyses, we used a staging system that is similar to the Braak staging system, but we acknowledge that tau PET to stage AD pathology is still developing and other staging systems may produce different results (Jack et al, 2016b).